Thus, a significant differential expression of HOTTIP and HOXA13 gene were screened out among the 1443 genes, and was invalided later both in cell lines and clinical samples, which indicates a close correlation between HOTTIP and HOXA13 gene and SCLC cell chemoresistance, as well as clinical outcome. This evidence concerns the gene HOXA13 and small cell lung carcinoma.